insights_auto
Outlook: 22.2% bullish·16.7% bearish
Go to analysischevron_right
A1RG34:BVMF
Argenx Se Bdr
165,44 R$
0,00%
(0,00) 1D
9 հոկ, 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
165,44 R$
High
165,44 R$
Low
165,44 R$
Mkt. cap
50,06 մլրդ
Avg. vol.
59,00
Volume
8,00
52-wk high
213,15 R$
52-wk low
143,22 R$
Shares outstanding
62,89 մլն
No. of employees
2 հզր
Open
165,44 R$
High
165,44 R$
Low
165,44 R$
Mkt. cap
50,06 մլրդ
Avg. vol.
59,00
Volume
8,00
52-wk high
213,15 R$
52-wk low
143,22 R$
Shares outstanding
62,89 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Simply Wall Street
·
6 ժամ առաջ
Could A Halted Sjögren Trial Alter The Investment Case For argenx Stock?
Yahoo Finance
·
11 ժամ առաջ
argenx (ENXTBR:ARGX) Stock May Be Fully Priced After Its 185% Run
AD HOC NEWS
·
1 օր առաջ
Argenx stock at EUR 724.80, market value USD 50.7 billion
Investing.com
·
1 օր առաջ
H.C. Wainwright reiterates argenx stock buy rating on celiac drug data
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr